Sana Biotechnology
We believe we are entering a new era of medicine. The ability to modify genes and use cells as medicines provides new tools to meaningfully change the outcome of many human diseases. Early pioneers have made good progress, but most of what we can deliver for patients remains in front of us. Sana was founded with the long view - bringing together great people and the best technologies to deliver on the challenging promise of engineered cells as medicines. Three aspirations drive Sana as we look to treat patients with poor outcomes or currently untreatable diseases. We understand that achieving our goals will be hard. It will take decades of commitment, and we recognize Sana cannot do it alone. There will be setbacks and even failures. However, the transformative potential of progress towards our aspirations motivates us to give our best every day. We are developing platforms that can repair and control genes in cells or replace any cell in the body.
Company details
Find locations served, office locations
- Business Type:
- Manufacturer
- Industry Type:
- Pharmaceuticals
- Market Focus:
- Nationally (across the country)
About Us
- Repair and control genes in any cell: In the area classically thought of as gene therapy, we are investing in both delivery and gene modification capabilities.
- Replace any cell in the body: The convergence of stem cell biology and immunology means we have the potential to replace missing or damaged tissue in the body.
- Tear down barriers to accessing our therapies: Scalable manufacturing with a focus on the cost of manufacturing, and working to align with key stakeholders will enable broader patient access to our therapies.